High tech, biotech clashing on patent bill
28653
Biotech and high technology, two key Massachusetts industries, are often seen as allies -- innovation-driven businesses that depend on a highly educated workforce. But this week they're on opposite sides of a fight playing out in Washington: How to overhaul the nation's patent system.
381938
There's a brawl brewing as Congress works up the most sweeping overhaul of the patent system in half a century.
199190
Nanotechnology is confronting the U.S. with a familiar problem - assessing claims of innovation that do not match up neatly with the way patent examiners are trained to categorize them.
550204
CHICAGO/NEW YORK  - When it comes to the price tag  for the newest biotechology drugs for cancer and other  hard-to-treat diseases, the sky is likely to remain the limit,  insurers, drugmakers and industry watchers say.
174211
A drug manufacturer has been found to infringe patents licensed by the maker of a rival drug.
341332
A month after a new U.S. law  encouraging the development of medicines to counter  bioterrorism, some drugmakers are lobbying for more incentives  to make products that may never be used.
247207
U.S. lawmakers returning from their  summer break are expected to consider patent law changes that  have pitted two of America's most invention-dependent  industries against each other.
250800
Proposed legislation for overhauling the U.S. patent system would either hurt a system that's worked for 200 years, or fix a badly broken mess, or cost more money, or save more, or raise intellectual-property values, or lower them... yes, the lobbyists have been busy on Capitol Hill as the reform debate continues.
312645
IN BASEBALL lingo, Senator Kennedy went one for two last week. His immigration bill went down to defeat, but the Senate health committee approved unanimously a compromise bill setting out a pathway for approval of copycat versions of high-cost biotechnology medicines. The bill balances the interests of the pioneering companies that first develop the medications -- used to treat diseases ...
231400
WASHINGTON -- Biotechnology lobbyists attempting to slow the development of cheap generic versions of the world's most expensive drugs have been emphasizing questions about their safety in an effort to win support among the new Democratic leaders of Congress.
202594
Is a man-made microorganism patentable? The J. Craig Venter Institute is about to find out, even as ETC Group challenges the patent bid.
226441
Biotechnology companies are betting that pairing old drugs can be a better business than inventing new ones from scratch.
704677
Washington area biotech companies will face pivotal moments this year, finding out whether key products work before money dries up, fending off competition from bigger companies,  and, perhaps filing to go public.
519192
Some high-profile scientists have jumped into the fight over the University of Wisconsin-Madison's stem cell patents, supporting the effort to have them revoked.
33718
Will the drugmaker's hefty R&D bill pay off?
411558
The pharmaceutical sues over patent infringement.
186774
Will the product patents regime lead to unsustainably high drug prices? A demonstration against patenting of drug products in Chennai.